Key statistics dashboard for BioRestorative Therapies, Inc. (BRTX). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
BioRestorative Therapies, Inc. is a life sciences company dedicated to developing regenerative medicine products and therapies. Their approach primarily utilizes adult stem cell protocols to address two key areas: disc/spine disease and metabolic disorders. Within their disc/spine program, known as brtxDisc, the company's leading cell therapy candidate is BRTX-100.
Stock Data
| Price | $2.55 |
| Market Cap | $4M |
| Enterprise Value | $443710 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -0.12 |
| Price / Book | 0.77 |
| P/S | 10.19 |
| EV/EBITDA | -0.04 |
| EV/Sales | 1.24 |
| EV/FCF | -0.04 |
| P/FCF | -0.31 |
| Earnings Yield | -489.17% |
| FCF Yield | -337.82% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 92.09% |
| EBIT Margin | -3089.55% |
| EBITDA Margin | -3030.70% |
| Operating Margin | -3975.00% |
| Net Margin | -3089.55% |
| Return on Equity | -423.84% |
| Return on Assets | -238.27% |
| Return on Invested Capital | -464.86% |
| Return on Capital Employed | -470.16% |
Financial Health
| Current Ratio | 2.35 |
| Quick Ratio | 2.35 |
| Cash Ratio | 1.93 |
| Debt / Equity | 0.01 |
| Debt / Assets | 0.74% |
| Net Debt / EBITDA | 0.28 |
| Interest Coverage | 0.00 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -69.34 |
Per-Share Data
| Revenue per share | 0.40 |
| Book Value per share | 3.41 |
| Cash per share | 4.05 |
| FCF per share | -13.42 |
| Tangible Book Value per share | 2.84 |
| Dividend per share | 0.00 |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 3 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 3 |
| Avg rating (1-5) | 1.00 |
Related companies: BOLT · COCP · DWTX · EDSA · EVGN · IMNN · IMRN
Explore sector: Healthcare · Biotechnology
More sections of BRTX: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks